Διακηρυξη 04/2025

This tender, identified as ΔΙΑΚΗΡΥΞΗ 04/2025, is being issued by a contracting authority within Greece and seeks the supply of blood-grouping reagents. The procurement is being conducted through the official channels of the Publications Office of the European Union, as indicated by its presence on the TED (Tenders Electronic Daily) platform, specifically TED notice 152387-2026.

The contract type is classified as 'Supplies', signifying that the primary objective is the acquisition of tangible goods. Blood-grouping reagents are critical diagnostic tools used in medical laboratories and healthcare settings for blood transfusions, paternity testing, and various other clinical applications. Companies specializing in the manufacture and distribution of in-vitro diagnostic products are expected to be the primary bidders.

Typical requirements for such a tender would encompass the provision of a comprehensive range of blood-grouping reagents, potentially including ABO, Rh (D), and other blood group antigen typing reagents. Bidders will likely need to demonstrate compliance with relevant European Union directives and national regulations pertaining to medical devices and laboratory consumables. This may involve providing certifications, quality assurance documentation, and evidence of established supply chain management to ensure timely and reliable delivery. Furthermore, specifications regarding product efficacy, shelf-life, packaging, and storage conditions are anticipated. Successful bidders will be expected to maintain high standards of product quality and customer support.